Landos Biopharma (LABP) Publishes Results of NX-13 Phase 1b

Landos Biopharma (LABP) Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis

Landos Biopharma (LABP) Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Fabio Cataldi , Bram Verstockt , Nasdaq , Landos Biopharma Inc , Landos Biopharma , Executive Vice President , Chief Medical Officer , Clinical Efficacy , Active Ulcerative Colitis ,